TLPH - Talphera Inc Market Cap to Sales Volume

Corporate company logo of Talphera Inc (TLPH)

Talphera, Inc. (TLPH) is fighting for a place in hospital regulations amid aggressive market consolidation. This daily price chart from the GURU.Markets platform shows the company's market cap-to-revenue ratio, where the value 1451.40 characterizes this level. The Zalviso system provides a competitive edge by allowing clinics to effectively mitigate pain. Operating within the US legal framework without geopolitical risks guarantees business stability.

Price-to-Revenue Ratio: talphera.com (TLPH) for 02/21/2024 - 05/14/2026

Analytical breakdowns for Talphera Corp (TLPH)

- price and consensus price forecast:
Market Chart talphera.com|TLPH - Consensus Target
- market capitalization statistics:
Market Value Talphera Corp|TLPH - Enterprise Value
- book capitalization information:
Book Value per Share Talphera|TLPH - Company Book Value|Market Value to Book Value Ratio talphera.com|TLPH - Aggregate Company Assets
- debt obligations and liquidity statistics:
Aggregate Debt to Equity Talphera, Inc.|TLPH - Long-Term Debt to Capital|Ratio of Short-Term Indebtedness to Capital Talphera Corporation|TLPH - Company Aggregate Debts|Debts to Book Value Talphera Corp|TLPH - Company Long-Term Debt|Company Short-Term Loans and Borrowings Talphera|Quick Ratio talphera.com
- company profitability and valuation multiples indicators:
TLPH - Net Income|Expected Net Income Talphera, Inc.|TLPH - P/E Multiple|Market Cap to Projected Earnings Talphera Inc|TLPH - Price/Earnings to Growth Ratio|Enterprise Value to Operating Income Before Depreciation Talphera Corp|TLPH - Operating profit EBITDA|Net earnings per share for the last 12 months Talphera|TLPH - Net earnings per share for the last 12 months|Year-over-year net earnings per share change for the last twelve months talphera.com|TLPH - Net earnings per share growth this year|Projected earnings per share increase next year Talphera, Inc.
- total revenue and sales volume data:
TLPH - Company Revenue|Company Projected Revenue talphera.com|TLPH - Price-to-Revenue Ratio|Future Price to Revenue Talphera Corp
General company analysis:TLPH - talphera.com
Flagship merchandise of Talphera Corporation

For an investor, the valuation of Talphera, Inc. (TLPH) within the specialty pharmaceuticals sector requires an analysis of the monetization efficiency of its innovative drug delivery platforms. The P/S ratio determines the market value of one dollar of revenue, correlating market capitalization with actual sales volume. Analyzing the P/S of Talphera, Inc. on GURU.Markets reveals a current value of 1451.40, which reflects market expectations regarding the success of clinical trials. The dynamics of this indicator provide insight into the long-term fundamental stability of the business.

Competitors of Talphera, Inc.

Price-to-Revenue Coefficient gilead.com|Cidara Therapeutics Inc - Market Cap to Revenue|Market Cap to Sales Volume NVAX (Novavax Inc)|CureVac Corp - P/S Multiple|VALN - P/S Multiple|Vir Biotechnology, Inc. (VIR) - Price-to-Revenue Ratio|SIGA (siga.com) - Price-to-Revenue Ratio|Price-to-Revenue Ratio Emergent BioSolutions Inc.|Atea Pharma - Price-to-Sales Ratio|P/S Multiple IVVD|ENTA (Enanta Pharmaceuticals, Inc) - Market Capitalization-to-Revenue Ratio|P/S Multiple INO (Inovio Pharmaceuticals)|hillevax.com (HLVX) - Price to Sales|KLRS - Price-to-Revenue Ratio|Market Capitalization-to-Revenue Ratio DYAI (Dyadic International)|NNVC: P/S Multiple|Cocrystal Pharma Corp (COCP) - P/S Multiple|Market Cap to Revenue TRAW|DWTX: Market Capitalization-to-Revenue Ratio|P/S Multiple QLGN|Price-to-Revenue Coefficient allovir.com|Price-to-Revenue Ratio VBI Vaccines VBIV|VIRI: Market Cap to Revenue Ratio|Vaxart Corp - P/S Multiple